
Sign up to save your podcasts
Or
The business of life sciences came into sharp focus after the pandemic highlighted the effectiveness of mRNA vaccines in protecting people against COVID. But what exactly is life sciences and is the recent market weakness a threat to future innovation — or an opportunity? In the latest episode of Exchanges at Goldman Sachs, Amit Sinha, head of Life Sciences Investing in Goldman Sachs Asset Management, discusses the evolution of life sciences and how investors are approaching the risks and opportunities within the biotechnology sector.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.2
905905 ratings
The business of life sciences came into sharp focus after the pandemic highlighted the effectiveness of mRNA vaccines in protecting people against COVID. But what exactly is life sciences and is the recent market weakness a threat to future innovation — or an opportunity? In the latest episode of Exchanges at Goldman Sachs, Amit Sinha, head of Life Sciences Investing in Goldman Sachs Asset Management, discusses the evolution of life sciences and how investors are approaching the risks and opportunities within the biotechnology sector.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1,199 Listeners
189 Listeners
94 Listeners
2,174 Listeners
1,784 Listeners
804 Listeners
1,026 Listeners
84 Listeners
181 Listeners
58 Listeners
1,264 Listeners
80 Listeners
414 Listeners
22 Listeners
70 Listeners